Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia

International Journal of Colorectal Disease

Volumn 31, Issue 3, 2016, Pages 543-551

  Calleja, José Luis ^a   Delgado, Salvadora ^b   del Val, Adolfo ^c   Hervás, Antonio ^d   Larraona, José Luis ^e   Terán, Álvaro ^f   Cucala, Mercedes ^g   Mearin, Fermín ^h  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g Vifor (International) Inc   (Switzerland)

^h CENTRO MÉDICO TEKNON   (Spain)

Author keywords

Colon cancer surgery; Ferric carboxymaltose; Iron deficiency anemia; Iron intravenous administration

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; FERRIC ION; IRON; MALTOSE;

AGED; ANEMIA; ARTICLE; CANCER PATIENT; CANCER SURGERY; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; ELECTIVE SURGERY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMICOLECTOMY; HEMOGLOBIN BLOOD LEVEL; HEMOPERITONEUM; HOSPITAL ADMISSION; HUMAN; HYPERSENSITIVITY; IRON METABOLISM; IRON THERAPY; LAPAROSCOPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPERATIVE BLOOD LOSS; PARALYTIC ILEUS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM HEMORRHAGE; SIGMOIDECTOMY; SURGICAL APPROACH; THROMBOEMBOLISM; TUMOR LOCALIZATION; UNSPECIFIED SIDE EFFECT; WOUND DEHISCENCE; ALLOTRANSPLANTATION; ANALOGS AND DERIVATIVES; BLOOD; BLOOD TRANSFUSION; CLINICAL TRIAL; COLONIC NEOPLASMS; COMPLICATION; MEAN CORPUSCULAR VOLUME; METABOLISM; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

AGED; ANEMIA; BLOOD TRANSFUSION; COLONIC NEOPLASMS; ERYTHROCYTE INDICES; FEMALE; FERRIC COMPOUNDS; HEMOGLOBINS; HUMANS; IRON; LENGTH OF STAY; MALE; MALTOSE; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84959341801     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-015-2461-x     Document Type: Article

References (25)

1. Shander A, Knight K, Thurer R et al (2004) Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 116(Suppl 7A):58S–69S. doi:10.1016/j.amjmed.2003.12.013
2. Edna T-H, Karlsen V, Jullumstrø E, Lydersen S (2012) Prevalence of anaemia at diagnosis of colorectal cancer: assessment of associated risk factors. Hepato-Gastroenterology 59:713–716. doi:10.5754/hge11479
3. Ward DG, Roberts K, Brookes MJ et al (2008) Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol 14:1339–1345
4. Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117:4425–4433. doi:10.1182/blood-2011-01-258467
5. Beattie WS, Karkouti K, Wijeysundera DN, Tait G (2009) Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 110:574–581. doi:10.1097/ALN.0b013e31819878d3
6. Musallam KM, Tamim HM, Richards T et al (2011) Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 378:1396–1407. doi:10.1016/S0140-6736(11)61381-0
7. Leichtle SW, Mouawad NJ, Lampman R et al (2011) Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg 212:187–194. doi:10.1016/j.jamcollsurg.2010.09.013
8. Myers E, O’Grady P, Grady PO, Dolan AM (2004) The influence of preclinical anaemia on outcome following total hip replacement. Arch Orthop Trauma Surg 124:699–701. doi:10.1007/s00402-004-0754-6
9. Cladellas M, Bruguera J, Comín J et al (2006) Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement? Eur Heart J 27:1093–1099. doi:10.1093/eurheartj/ehi830
10. Kotzé A, Carter LA, Scally AJ (2012) Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 108:943–952. doi:10.1093/bja/aes135
11. Amato AC, Pescatori M (1998) Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum 41:570–585
12. Acheson AG, Brookes MJ, Spahn DR (2012) Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 256:235–244. doi:10.1097/SLA.0b013e31825b35d5
13. Leal-Noval SR, Muñoz M, Asuero M et al (2013) 2013: The Seville document on consensus on the alternatives to allogenic blood transfusion. Update to the Seville document. Spanish Societies of Anaesthesiology (SEDAR), Haematology and Haemotherapy (SEHH), Hospital Pharmacy (SEFH), Critical Care Medicine (SEMICYUC), Thrombosis and Haemostasis (SETH) and Blood Transfusion (SETS). Farm Hosp Órgano Of Expr Científica Soc Esp Farm Hosp 37:209–235. doi:10.7399/FH.2013.37.3.133
14. Bisbe Vives E, Basora Macaya M (2015) Algorithm for treating preoperative anemia. Rev Esp Anestesiol Reanim 62:27–34
15. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S et al (2015) “Fit to fly”: overcoming barriers to preoperative haemoglobin optimization in surgical patients†. Br J Anaesth 115:15–24. doi:10.1093/bja/aev165
16. Keating GM (2015) Ferric carboxymaltose: a review of its use in iron deficiency. Drugs 75:101–127. doi:10.1007/s40265-014-0332-3
17. Dignass AU, Gasche C, Bettenworth D et al (2015) European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 9:211–222. doi:10.1093/ecco-jcc/jju009
18. Bisbe E, García-Erce JA, Díez-Lobo AI et al (2011) A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 107:477–478. doi:10.1093/bja/aer242
19. Cladellas M, Farré N, Comín-Colet J et al (2012) Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol 110:1021–1026. doi:10.1016/j.amjcard.2012.05.036
20. Muñoz M, Gómez-Ramírez S, Cuenca J et al (2014) Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion (Paris) 54:289–299. doi:10.1111/trf.12195
21. Kotz D, Nelemans P, van Schayck CP, Wesseling GJ (2008) External validation of a COPD diagnostic questionnaire. Eur Respir J 31:298–303. doi:10.1183/09031936.00074307
22. Organization WH (2011) Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Concentrations en hémoglobine permettant de diagnostiquer l’anémie et d’en évaluer la sévérité
23. Hernandez Cera C, Cantero C, Rivas Ferreira E et al (2011) Efficacy of protocol implementation based on intravenous iron treatment in gastrointestinal cancer surgery. Eur J Anaesthesiol 28:13–14
24. Edwards TJ, Noble EJ, Durran A et al (2009) Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. Br J Surg 96:1122–1128. doi:10.1002/bjs.6688
25. Gargano G, Fanizza G, Polignano G et al (1999) A new protocol of iron therapy combined with epoetin alpha as a treatment for preoperative autologous blood donation in gynaecological tumor surgery. Oncol Rep 6:1349–1352